Advantage Alpha Capital Partners LP Buys Shares of 95,021 Option Care Health, Inc. (NASDAQ:OPCH)

Advantage Alpha Capital Partners LP bought a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 95,021 shares of the company's stock, valued at approximately $2,974,000. Advantage Alpha Capital Partners LP owned 0.06% of Option Care Health at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. UMB Bank n.a. raised its position in shares of Option Care Health by 937.5% during the third quarter. UMB Bank n.a. now owns 830 shares of the company's stock valued at $26,000 after buying an additional 750 shares during the last quarter. GAMMA Investing LLC lifted its position in shares of Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company's stock worth $28,000 after acquiring an additional 471 shares during the period. Whittier Trust Co. of Nevada Inc. lifted its position in shares of Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock worth $47,000 after acquiring an additional 1,446 shares during the period. Blue Trust Inc. grew its holdings in shares of Option Care Health by 14.8% during the 2nd quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock worth $81,000 after purchasing an additional 377 shares in the last quarter. Finally, International Assets Investment Management LLC grew its holdings in shares of Option Care Health by 3,029.7% during the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock worth $91,000 after purchasing an additional 2,757 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts recently commented on OPCH shares. The Goldman Sachs Group cut Option Care Health from a "buy" rating to a "neutral" rating and reduced their target price for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Truist Financial decreased their target price on shares of Option Care Health from $41.00 to $34.00 and set a "buy" rating on the stock in a research report on Friday, November 1st. Bank of America lowered Option Care Health from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $43.00 to $29.00 in a research note on Wednesday, October 30th. Jefferies Financial Group downgraded shares of Option Care Health from a "buy" rating to a "hold" rating and reduced their target price for the company from $38.00 to $26.00 in a research note on Thursday, October 31st. Finally, JMP Securities increased their target price on shares of Option Care Health from $36.00 to $37.00 and gave the stock a "market outperform" rating in a research report on Monday, September 30th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Option Care Health currently has a consensus rating of "Moderate Buy" and a consensus target price of $30.83.

Option Care Health Price Performance

Shares of Option Care Health stock traded up $0.34 during trading on Tuesday, reaching $23.74. The company's stock had a trading volume of 2,192,743 shares, compared to its average volume of 1,544,212. The stock has a 50-day moving average price of $27.45 and a two-hundred day moving average price of $29.05. The stock has a market capitalization of $4.04 billion, a P/E ratio of 19.95, a price-to-earnings-growth ratio of 2.39 and a beta of 1.32. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $34.63.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 43,000 shares of the firm's stock in a transaction that occurred on Friday, November 8th. The shares were acquired at an average price of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the acquisition, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 0.64% of the company's stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.